| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Vitamin b12 metabolism 0.917634493096298 2.652101094092822 0.0079992587320891 0.9919885707086638 0.4311686189993647 9 P01130,Q8WTV0 2 |
| Glycosaminoglycan degradation 0.9851301115241636 2.6382398751344964 0.0083337609217482 0.993458424184632 0.4311686189993647 7 P15586,P08236,P07686,P16278,P51688,P06865 6 |
| Degradation pathway of sphingolipids including diseases 0.9816536778346622 2.6252828384858087 0.0086577016209461 0.9946246615883576 0.4311686189993647 7 P07686,P15289,P06280,P06865,P17900 5 |
| Arrhythmogenic right ventricular cardiomyopathy 0.7643936750396364 2.3982090958876414 0.0164754573505814 0.9999538782042804 0.4539787893936064 15 P05556,P14923,Q14126,P15924,P06756,P19022 6 |
| Selenium micronutrient network 0.800387926237391 2.3619305840067866 0.0181800459809076 0.9999837391068144 0.4539787893936064 12 P01130 1 |
| Sphingolipid pathway 0.8064412164468693 2.2827312844347563 0.0224462018033215 0.9999988127528184 0.4539787893936064 11 Q9NRA0,Q13510,Q96G23,P04062 4 |
| Primary focal segmental glomerulosclerosis fsgs 0.6906254223050337 2.264324413348483 0.0235541691117191 0.9999993994607034 0.4539787893936064 19 P05556,O00592,Q14108,P06756,P19022 5 |
| Ebola virus infection in host 0.595104702262214 2.260917565037887 0.0237643622182286 0.9999994723459746 0.4539787893936064 45 P78536,P04439,P08069,P05556,P01889,P61916,O15118,P51151,Q07021,P10321,P06756 11 |
| Nephrotic syndrome 0.7707408031780478 2.2291306485309237 0.0258052132175197 0.9999998499878208 0.4659208525319381 12 O75844,O00592,Q14108 3 |
| Calcium regulation in cardiac cells 0.6355817126890488 2.198566845665701 0.0279087365909314 0.9999999590804342 0.4659208525319381 28 P04899,P0DP25,P08754,P54709,P63096,Q13555,P62942,P27797,Q14012,P10644,P05026,P61981 12 |
| Sphingolipid metabolism in senescence 0.7795555236158961 2.1656760886675284 0.0303359474786963 0.9999999908925096 0.4765549981574614 11 P16278,Q13510,P04062 3 |
| 7oxoc and 7betahc pathways 0.78726674832186 2.1153710276032225 0.0343983371023337 0.9999999992695324 0.4906681174713836 9 P61916,O15118 2 |
| Sphingolipid metabolism integrated pathway 0.7800242890439273 2.084452544236538 0.0371190225853113 0.99999999986599 0.4906681174713836 9 Q9NRA0,O95470,Q13510,Q96G23 4 |
| Complement system 0.7369361156277837 2.0748805483120063 0.0379976069119245 0.9999999999225774 0.4906681174713836 12 P04899,P07942,P98164,P27797,P26885,Q07021 6 |
| Development of ureteric collection system 0.9010938824080684 2.0662983866235938 0.0388003136747423 0.9999999999531202 0.4906681174713836 5 O94813,Q5SZK8 2 |
| Sphingolipid metabolism overview 0.7845966642684303 2.041761394901219 0.0411752053951508 0.9999999999894004 0.4906681174713836 8 Q9NRA0,O95470,Q13510,Q96G23 4 |
| Ferroptosis 0.6171210246327108 2.037126226519395 0.0416373943278545 0.9999999999920668 0.4906681174713836 26 Q96QD8,P45880,P02786,P08195,P02792,Q9UPY5,Q15043,Q9Y277,Q9NZ45 9 |
| Statin inhibition of cholesterol production 0.8668071337796517 1.999498793287795 0.0455544122987301 0.9999999999993232 0.5099930003510592 6 P01130,Q8WTV0 2 |
| 1q211 copy number variation syndrome 0.7483444942189652 1.947835031264733 0.0514347056443911 0.9999999999999836 0.5520046087906976 9 Q9Y624,Q9NPH0 2 |
| S1p receptor signal transduction 0.7450801270488188 1.9336310558196304 0.0531585060920645 0.9999999999999944 0.5566531245886598 9 Q9H0H5,P04899,P63096,Q9NRA0,P31751,Q13510 6 |
| Ketogenesis and ketolysis 0.8419820137479712 1.9039861502643711 0.0569119879546229 0.9999999999999994 0.5566531245886598 6 P23786 1 |
| Copper homeostasis 0.7373863629527642 1.9000610046963704 0.0574251143502444 0.9999999999999996 0.5566531245886598 9 P05067,P35670 2 |
| Inclusion body myositis 0.983297247138879 1.8569401158038457 0.0633196743898618 1.0 0.5745957896177815 2 P05067 1 |
| Complement system in neuronal development and plasticity 0.7079282159638016 1.845172139021652 0.065012501986704 1.0 0.5745957896177815 11 Q5KU26,P06756 2 |
| Genes controlling nephrogenesis 0.8329062607748597 1.8033330065526791 0.0713359319472193 1.0 0.6038435929616733 5 O94813 1 |
| Pathogenic escherichia coli infection 0.5877105039937958 1.7941870729652654 0.072783314750717 1.0 0.6064444490962093 23 Q16625,Q9BUF5,O15144,P05556 4 |
| Familial hyperlipidemia type 3 0.9805074257425744 1.7442309776089575 0.0811188217210436 1.0 0.6226309295156968 3 P01130,Q8WTV0 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7971970137153577 1.7293774108750122 0.0837415701857642 1.0 0.6238612700484459 6 Q14739,Q9UBM7 2 |
| Familial hyperlipidemia type 4 0.8956212496666578 1.7238282596428145 0.0847388513872382 1.0 0.6238612700484459 4 P01130 1 |
| Allograft rejection 0.6993558954062535 1.7209120461263987 0.0852667853393771 1.0 0.6238612700484459 10 P04439,P10321,P01889 3 |
| Zinc homeostasis 0.8875862932396437 1.6932862951605487 0.0904009854949459 1.0 0.6238612700484459 4 Q8NEW0,Q15043 2 |
| Metabolic pathway of ldl hdl and tg including diseases 0.9615043259261452 1.672654569085272 0.0943953176695391 1.0 0.6238612700484459 3 P01130 1 |
| Familial hyperlipidemia type 1 0.9602796841637392 1.6680367728895835 0.0953084271295341 1.0 0.6238612700484459 3 P01130 1 |
| Familial hyperlipidemia type 5 0.9602796841637392 1.6680367728895835 0.0953084271295341 1.0 0.6238612700484459 3 P01130 1 |
| Vitamin d metabolism 0.958646117006321 1.6618761938520792 0.0965376008560823 1.0 0.6238612700484459 3 P04062 1 |
| Purinergic signaling 0.7950287077596512 1.6546686799586272 0.0979917235737746 1.0 0.6265215517855164 5 P63096,P04899,Q96RD7 3 |
| Tyrobp causal network in microglia 0.7290723542481974 1.6256550978012747 0.1040230471406509 1.0 0.644513931252899 7 Q15758,P61916,Q15418 3 |
| Spinal cord injury 0.5658623605115607 1.610547986206171 0.107278278447128 1.0 0.651255003502262 20 Q08722,Q9NQC3,P08670,P17931,O94813 5 |
| Splicing factor nova regulated synaptic proteins 0.5868655325933522 1.562743670913305 0.1181128981073311 1.0 0.6972379380953307 16 Q9NYB0,Q92859 2 |
| Mitochondrial complex iv assembly 0.6173443583704319 1.5539125030305805 0.1202052889259859 1.0 0.6972379380953307 13 Q7KZN9,P20674,Q9Y2R0,Q9Y6N1,P00403,P14406 6 |
| Proteoglycan biosynthesis 0.7685623805172972 1.549876887527584 0.1211710680331528 1.0 0.6972379380953307 5 Q9NX62,Q8TB61,Q8NCH0 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.8324529413518378 1.4826257843167034 0.1381738626538569 1.0 0.7345567444945834 4 Q10472,Q9NRA0 2 |
| Notch signaling 0.6939793511099315 1.4782773454143197 0.1393335588558777 1.0 0.7345567444945834 7 Q92542 1 |
| Notch signaling pathway 0.5893030051036583 1.4624291647357734 0.1436236422404828 1.0 0.7499401043284517 14 P78536,Q96J02,Q92542 3 |
| Sarscov2 and covid19 pathway 0.8235013162198137 1.448299864691491 0.1475332055059768 1.0 0.7499401043284517 4 Q8WTV0 1 |
| Alzheimers disease and mirna effects 0.4455975670150915 1.4457300244825515 0.1482529395956293 1.0 0.7499401043284517 86 P78536,Q07954,P45880,P0DP25,P21796,Q9NQC3,P67870,P05067,O95197,O00459,P20618,Q9Y277,Q92542,Q96IX5,P49721,P28072 16 |
| Glucocorticoid receptor pathway 0.7252242787152532 1.4433691366421573 0.148916513468154 1.0 0.7499401043284517 6 P27105 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.806561436087886 1.3833080441126735 0.1665704325588066 1.0 0.7751619583137039 4 Q15758,Q9UPY5,P08195 3 |
| Alzheimers disease 0.4402978853182862 1.3801722372547804 0.1675336198716426 1.0 0.7751619583137039 84 P78536,Q07954,P45880,P0DP25,P21796,Q9NQC3,P67870,P05067,O95197,O00459,Q9Y277,Q92542,P49721,P28072 14 |
| Striated muscle contraction pathway 0.7083439511700154 1.3755406963862364 0.1689638778644586 1.0 0.7751619583137039 6 P28289,P67936,P08670,P06753 4 |
| Network map of sarscov2 signaling pathway 0.5050404716324478 1.324768372224583 0.1852479879269217 1.0 0.7982174973848607 25 Q07021,Q9UBR2,Q08380,Q96J02 4 |
| Reninangiotensinaldosterone system raas 0.8691212871287199 1.3239745283007922 0.1855115043441229 1.0 0.7982174973848607 3 Q14012,P0DP25 2 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.7851941296998319 1.301345938905038 0.1931400693407079 1.0 0.7982174973848607 4 O00584 1 |
| Prostaglandin and leukotriene metabolism in senescence 0.8493659140117423 1.2996405371474171 0.1937241992450178 1.0 0.7982174973848607 2 P09960 1 |
| Metapathway biotransformation phase i and ii 0.5050304395196468 1.2760298044930425 0.2019449834866789 1.0 0.8025273029588952 22 Q6UW02,Q8NCH0,Q7LGA3,P07099,O43708,Q86UY6 6 |
| Rala downstream regulated genes 0.6796155881140391 1.2597018651076386 0.2077769323187577 1.0 0.8161695184547281 6 P11233,P16989 2 |
| Kennedy pathway from sphingolipids 0.6936676483870189 1.2507316671601767 0.2110323928685364 1.0 0.8182610846063898 5 P35790 1 |
| Malignant pleural mesothelioma 0.4225892462581942 1.1660391088969635 0.2435986336556512 1.0 0.8781203008862254 74 Q08722,P07942,P05556,P08195,O00592,P67870,P51812,Q14574,Q15418,O14578,P06756,P19022 12 |
| Small cell lung cancer 0.5228213995404116 1.1589422081318852 0.2464797426744045 1.0 0.8781203008862254 15 P06756,P07942,P05556 3 |
| Proximal tubule transport 0.5395668196344231 1.1572185306506009 0.2471830886950732 1.0 0.8781203008862254 13 Q9Y5K8,P08195,P05026 3 |
| Folate metabolism 0.5110142395911456 1.1436469798137463 0.2527700699722413 1.0 0.8781203008862254 16 P01130 1 |
| Endochondral ossification with skeletal dysplasias 0.5771007942876757 1.1281114138047412 0.259272869414394 1.0 0.8802005136523522 8 Q96QD8 1 |
| Endochondral ossification 0.5771007942876757 1.1281114138047412 0.259272869414394 1.0 0.8802005136523522 8 Q96QD8 1 |
| Proteasome degradation 0.4474641996252548 1.1247578354602494 0.260691666273076 1.0 0.8802005136523522 41 P04439,P10321,P01889,P49721 4 |
| P53 transcriptional gene network 0.5644610735509855 1.1156840963401773 0.2645573804521819 1.0 0.8833276980653407 9 P04066 1 |
| Hippo signaling regulation pathways 0.4903849735097507 1.078428189593888 0.2808427124897181 1.0 0.8944289978691984 17 P08069,P04899,P10644,P19022 4 |
| Hippomerlin signaling dysregulation 0.4651727744885013 1.0530294477680815 0.292327495897666 1.0 0.9103047929248564 24 P08069,P19022,P06756,P05556 4 |
| Congenital generalized lipodystrophy cgl 0.7751314568512235 0.9975611494716552 0.3184922079600709 1.0 0.9408130354836084 2 P31751 1 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.4842085523341088 0.99259040117093 0.3209096044494837 1.0 0.9408130354836084 16 P08670,P05067 2 |
| Ectoderm differentiation 0.4550795672873556 0.9430373345355968 0.3456618068000949 1.0 0.9632520014844432 20 O00592 1 |
| Thermogenesis 0.4328040392303587 0.927706847222947 0.353559655680747 1.0 0.9632520014844432 30 P23786,Q15418,O43772 3 |
| Mitochondrial long chain fatty acid betaoxidation 0.4772758229894904 0.9092155685904786 0.3632363477942144 1.0 0.965951526656296 15 P23786 1 |
| Wnt signaling pathway and pluripotency 0.4549677658279126 0.8936723757597439 0.3714972096759126 1.0 0.970731681586634 18 P01130 1 |
| Hedgehog signaling pathway wp47 0.7435818125579976 0.8738687358784291 0.3821897424358098 1.0 0.970731681586634 2 O00422 1 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.5052624630104057 0.8406508225907299 0.4005435781039457 1.0 0.970731681586634 9 O95819,P05556 2 |
| Familial partial lipodystrophy fpld 0.5081845504402512 0.8168015280863422 0.4140418588304229 1.0 0.978419488372544 8 O75844,P31751,O75531 3 |
| Oxidation by cytochrome p450 0.5649470461140768 0.7999539626537995 0.4237374709185881 1.0 0.9820509328921364 6 O43169 1 |
| Ccl18 signaling pathway 0.488243096255835 0.7980399185181882 0.4248473253776297 1.0 0.9820509328921364 11 P08670,P19022 2 |
| Autosomal recessive osteopetrosis pathways 0.7125795588837618 0.7562230370613511 0.4495154828958247 1.0 1.0 3 P51798 1 |
| Neural crest differentiation 0.4816006291109435 0.7319426696551533 0.4642035607614305 1.0 1.0 9 P05556 1 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.4847888162814621 0.7129011463105602 0.4759069297903273 1.0 1.0 8 Q15418 1 |
| Orexin receptor pathway 0.4155474751452913 0.7056113603306594 0.4804298575477874 1.0 1.0 21 P01130,Q13595,P17096 3 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.6184185538656579 0.6830040662358543 0.4946042731168505 1.0 1.0 4 P19022 1 |
| Adipogenesis 0.4309372298221608 0.6554568496976182 0.5121736596176536 1.0 1.0 15 P43490,O75844,P17096 3 |
| Autophagy 0.4928018364560482 0.6286654371930951 0.5295681101479159 1.0 1.0 7 Q7Z3C6 1 |
| Angiopoietinlike protein 8 regulatory pathway 0.3896402102314288 0.624829210817685 0.53208315676661 1.0 1.0 31 P13807,Q14254,P31751,P41440,O95819,P51812,O00459,Q15418,O75955,Q15642 10 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.6498730059243095 0.5550634151781692 0.578851285507819 1.0 1.0 3 P49407 1 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.4983650221110961 0.5472462912879686 0.5842095371540479 1.0 1.0 6 Q14145,Q9UPY5 2 |
| Fatty acid betaoxidation 0.3865594763840088 0.5302072230783824 0.5959682635755015 1.0 1.0 22 P23786 1 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.4884866872811921 0.5117035548501669 0.6088584978210194 1.0 1.0 6 Q9UPY5 1 |
| Interactions between loxl4 and oxidative stress pathway 0.6328487472935385 0.4851037096014618 0.6276027807840467 1.0 1.0 2 Q16543 1 |
| Oxysterols derived from cholesterol 0.4547867237726425 0.4797296571558594 0.6314196368529332 1.0 1.0 7 Q9UBM7 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4178766448588928 0.4501822153692239 0.6525790588559284 1.0 1.0 9 P05556 1 |
| Folatealcohol and cancer pathway hypotheses 0.6145994432415746 0.4310385857623284 0.6664403144668378 1.0 1.0 2 P11766 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3608154734689199 0.4193393915266314 0.6749681118494721 1.0 1.0 31 P01130 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3952610470747582 0.3999749706059167 0.6891749520285757 1.0 1.0 12 Q96AY3,Q32P28,P07237,P13674,O75718 5 |
| Hepatitis b infection 0.3537342595963707 0.3328687688946311 0.7392333451559767 1.0 1.0 24 Q7Z434,O15111,Q15904,P31751,P31946,O00459,Q9Y277 7 |
| Wnt signaling in kidney disease 0.5697494587070868 0.3144846743679191 0.7531529545439697 1.0 1.0 2 P61586 1 |
| Oxidative phosphorylation 0.345273597593004 0.3106374459054657 0.7560762568147021 1.0 1.0 33 O96000,P03886,Q15904 3 |
| Nuclear receptors metapathway 0.3249984230986719 0.276813471251126 0.7819233366641747 1.0 1.0 53 P23786,P27105,P02792 3 |
| Dopamine metabolism 0.5365099009901044 0.2727743727800272 0.7850266603240179 1.0 1.0 3 P17612,P17252 2 |
| Tgfbeta receptor signaling 0.4139318885448891 0.250330685049032 0.8023316284789848 1.0 1.0 5 P35222,P62942,P27361,P40763 4 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.4139318885448891 0.250330685049032 0.8023316284789848 1.0 1.0 5 P35222,P62942,P27361,P40763 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3481114179038257 0.2453159642824113 0.8062117916378368 1.0 1.0 16 P55209 1 |
| Fibrin complement receptor 3 signaling pathway 0.5167079207920962 0.23744082085438 0.8123148245557013 1.0 1.0 3 P61586,O15111 2 |
| Sting pathway in kawasakilike disease and covid19 0.516707920792087 0.2374408208543654 0.8123148245557126 1.0 1.0 3 O15111,Q86UT6 2 |
| Supression of hmgb1 mediated inflammation by thbd 0.5167079207920862 0.2374408208543634 0.8123148245557141 1.0 1.0 3 O15111,P09429 2 |
| Ppar signaling pathway 0.3350570988088164 0.2193851146403825 0.8263500644054393 1.0 1.0 20 P23786 1 |
| Pkcgamma calcium signaling pathway in ataxia 0.5199505103618969 0.2154354220363183 0.8294278555222074 1.0 1.0 2 Q15118 1 |
| Quercetin and nfkb ap1 induced apoptosis 0.5165480977420394 0.2098845443922652 0.8337577853536047 1.0 1.0 2 Q14145 1 |
| Canonical nfkb pathway 0.5165480977420391 0.2098845443922647 0.8337577853536051 1.0 1.0 2 O15111 1 |
| Nodlike receptor nlr signaling pathway 0.5165480977420391 0.2098845443922647 0.8337577853536051 1.0 1.0 2 O15111 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.5165480977420391 0.2098845443922647 0.8337577853536051 1.0 1.0 2 O15111 1 |
| Photodynamic therapyinduced nfkb survival signaling 0.5165480977420391 0.2098845443922647 0.8337577853536051 1.0 1.0 2 O15111 1 |
| Integrinmediated cell adhesion 0.333753536494451 0.2092127624796558 0.8342821498589315 1.0 1.0 23 P05556,P31751,Q16512,P04632,Q14185,O00459,P06756 7 |
| Neuroinflammation 0.3952187597243334 0.2056172980192771 0.8370898643767184 1.0 1.0 5 Q8N9N2,P00403 2 |
| Cell migration and invasion through p75ntr 0.3951357860409688 0.2054297207726464 0.8372364015929774 1.0 1.0 5 P31751 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.3314823279925888 0.1958117818899344 0.8447574879775619 1.0 1.0 23 Q15392,Q14739,Q9UBM7,O76062 4 |
| Wnt signaling 0.340416234992536 0.1910876165985797 0.8484569493965015 1.0 1.0 15 Q8TAA9,P67870 2 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.3484003765693941 0.1821462869393971 0.8554679245372099 1.0 1.0 9 Q7Z434 1 |
| Mitochondrial complex i assembly model oxphos system 0.3264517759906106 0.1765513256869468 0.8598608298215875 1.0 1.0 29 O96000,Q8IUX1,P51970,P03886,O43676,Q9P032 6 |
| Disruption of postsynaptic signaling by cnv 0.3616083484572368 0.1709509934399875 0.8642622998084692 1.0 1.0 7 Q13555,P61981,Q7L576 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.4637995049505219 0.1651208933312029 0.8688488282334985 1.0 1.0 3 Q9P2K5,P31751 2 |
| Tp53 network 0.4732446643983961 0.1524073675636992 0.8788656464866678 1.0 1.0 2 Q13315 1 |
| Mirna regulation of p53 pathway in prostate cancer 0.4732446643983961 0.1524073675636992 0.8788656464866678 1.0 1.0 2 Q13315 1 |
| Leptininsulin signaling overlap 0.4636560470151608 0.1428063407632411 0.8864431292077883 1.0 1.0 2 O14654 1 |
| Glial cell differentiation 0.4454067429631968 0.1273492445877456 0.89866398601209 1.0 1.0 2 P09543 1 |
| Riboflavin and coq disorders 0.3518629816747504 0.1181615528022489 0.9059396529058592 1.0 1.0 6 Q86YH6 1 |
| Tlr4 signaling and tolerance 0.3834534515670328 0.1170114276645674 0.9068509977255784 1.0 1.0 4 Q15629 1 |
| Dna mismatch repair 0.3156173204310644 0.1101237115553894 0.9123112634209274 1.0 1.0 21 Q9UQ84,Q9NR33 2 |
| Extracellular vesiclemediated signaling in recipient cells 0.3754255648406223 0.1088630059849691 0.9133111491523334 1.0 1.0 4 P35222,Q9NWH9,P42345 3 |
| Canonical and noncanonical notch signaling 0.3545792079207915 0.1005364708643168 0.9199184299380244 1.0 1.0 3 O15111,P55081 2 |
| Pregnane x receptor pathway 0.3275541795665604 0.0856497117146299 0.9317448793866778 1.0 1.0 5 O15439,Q99615,P07900,P08183 4 |
| Focal adhesion 0.3093571929965097 0.0590108530325488 0.9529434637077508 1.0 1.0 36 P08069,P06756,P07942,P05556 4 |
| Insulin signaling in adipocytes normal condition 0.2838130609718396 0.0589196685973995 0.9530160919901944 1.0 1.0 4 P42345,P31751,P62753 3 |
| Insulin signaling in adipocytes diabetic condition 0.2838130609718396 0.0589196685973995 0.9530160919901944 1.0 1.0 4 P42345,P31751,P62753 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.3029299961434874 0.0548371613537668 0.956268194451248 1.0 1.0 8 Q6UWE0,P20337 2 |
| Insulin signaling 0.3044489612694394 0.0457365771306161 0.96352020996716 1.0 1.0 46 P10586,Q9H4M9,O00161,Q14254,P31751,P41440,O95819,P51812,O00459,Q15418,P08069,O75955,P13807 13 |
| Tgfbeta signaling pathway 0.306831149213925 0.044814240053577 0.9642553745752562 1.0 1.0 33 P05556,P05067,Q96J02 3 |
| Kit receptor signaling pathway 0.3012193615766428 0.0387756271095877 0.9690692769655772 1.0 1.0 17 P51812,Q15418 2 |
| Thyroid stimulating hormone tsh signaling pathway 0.3012078346623124 0.0349211214802089 0.9721426383778922 1.0 1.0 21 P04899,P63096,O00459,Q15418,P08069 5 |
| Cannabinoid receptor signaling 0.297521903209982 0.0309724127723618 0.9752915405323972 1.0 1.0 7 Q8NCG7 1 |
| G protein signaling pathways 0.3011104881323434 0.0291939370754016 0.9767099166873132 1.0 1.0 16 P04899,P63096,O43823,O43572,P10644 5 |
| Electron transport chain oxphos system in mitochondria 0.2931455823477809 0.0225534104376715 0.9820065074485532 1.0 1.0 55 O96000,P03886,Q15526,Q7KZN9,P20674,Q9UDW1,O43676,O14949,Q9Y6N1,P00403,P14406 11 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.2728629454573958 0.0073743837414201 0.994116146396166 1.0 1.0 6 P07099 1 |
| Epithelial to mesenchymal transition in colorectal cancer 0.2984659286159749 0.0038168415854228 0.9969546084223152 1.0 1.0 25 Q99959,P14923,P31751,Q16512,Q16625,O00459,P15924,P19022 8 |
|
|
